Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 748 JPY -0.52% Market Closed
Market Cap: ¥427.3B

P/OCF

16.7
Current
29%
Cheaper
vs 3-y average of 23.7

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
16.7
=
Market Cap
¥440.5B
/
Operating Cash Flow
¥25.6B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
16.7
=
Market Cap
¥440.5B
/
Operating Cash Flow
¥25.6B

Valuation Scenarios

Kobayashi Pharmaceutical Co Ltd is trading below its 3-year average

If P/OCF returns to its 3-Year Average (23.7), the stock would be worth ¥8 152.63 (42% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-31%
Maximum Upside
+50%
Average Upside
11%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 16.7 ¥5 748
0%
3-Year Average 23.7 ¥8 152.63
+42%
5-Year Average 25 ¥8 614.1
+50%
Industry Average 14.2 ¥4 882.66
-15%
Country Average 11.5 ¥3 942.35
-31%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
427.3B JPY 16.7 116.9
FR
L'Oreal SA
PAR:OR
201.5B EUR 23.3 32.9
UK
Unilever PLC
LSE:ULVR
93.4B GBP 10 11.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR 47.4 37.6
UK
HALEON PLC
LSE:HLN
31.6B GBP 12 19
US
Estee Lauder Companies Inc
NYSE:EL
28.1B USD 16.9 -158.1
DE
Beiersdorf AG
XETRA:BEI
15.8B EUR 20.1 16.8
JP
Kao Corp
TSE:4452
2.7T JPY 13.4 22.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 48.9 64.1
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 552.9 -4 624.4
IN
Dabur India Ltd
NSE:DABUR
815.9B INR 42.4 43.3
P/E Multiple
Earnings Growth PEG
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average P/E: 40.5
116.9
72%
1.6
FR
L'Oreal SA
PAR:OR
32.9
13%
2.5
UK
Unilever PLC
LSE:ULVR
11.3
-6%
N/A
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.6
7%
5.4
UK
HALEON PLC
LSE:HLN
19
11%
1.7
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -158.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
16.8
6%
2.8
JP
Kao Corp
TSE:4452
22.2
10%
2.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
64.1
18%
3.6
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
43.3
11%
3.9

Market Distribution

Higher than 72% of companies in Japan
Percentile
72st
Based on 4 634 companies
72st percentile
16.7
Low
0.1 — 8
Typical Range
8 — 16
High
16 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 8
Median 11.5
70th Percentile 16
Max 277 515 329.3

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
427.3B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
5 270.32 JPY
Overvaluation 8%
Intrinsic Value
Price ¥5 748
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett